Embecta Corp (NASDAQ:EMBC) — Market Cap & Net Worth
Market Cap & Net Worth: Embecta Corp (EMBC)
Embecta Corp (NASDAQ:EMBC) has a market capitalization of $183.92 Million ($183.92 Million) as of June 15, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16940 globally and #3957 in its home market, demonstrating a -9.09% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Embecta Corp's stock price $3.10 by its total outstanding shares 59327677 (59.33 Million). Review EMBC current and long-term liabilities to assess the company's total debt and financial obligations.
Embecta Corp Market Cap History: 2022 to 2026
Embecta Corp's market capitalization history from 2022 to 2026. Data shows change from $1.41 Billion to $183.92 Million (-48.60% CAGR).
Index Memberships
Embecta Corp is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 0.01% | #472 of 976 |
|
NASDAQ Composite
IXIC
|
$40.95 Trillion | 0.00% | #1674 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.66 Trillion | 0.06% | #578 of 602 |
Weight: Embecta Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Embecta Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Embecta Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.65x
Embecta Corp's market cap is 0.65 times its annual revenue
Latest Price to Earnings (P/E) Ratio
7.39x
Embecta Corp's market cap is 7.39 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.41 Billion | $1.13 Billion | $223.60 Million | 1.25x | 6.32x |
| 2023 | $1.09 Billion | $1.12 Billion | $70.40 Million | 0.97x | 15.44x |
| 2024 | $1.23 Billion | $1.12 Billion | $78.30 Million | 1.09x | 15.65x |
| 2025 | $704.81 Million | $1.08 Billion | $95.40 Million | 0.65x | 7.39x |
Competitor Companies of EMBC by Market Capitalization
Companies near Embecta Corp in the global market cap rankings as of June 15, 2026.
Key companies related to Embecta Corp by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #162 globally with a market cap of $145.58 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $98.90 Billion USD ( €84.60 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #344 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #537 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Intuitive Surgical Inc | NASDAQ:ISRG | $145.58 Billion | $411.06 |
| #258 | EssilorLuxottica S. A. | PA:EL | $98.90 Billion | €182.70 |
| #344 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €90.00 |
| #537 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Embecta Corp Historical Marketcap From 2022 to 2026
Between 2022 and today, Embecta Corp's market cap moved from $1.41 Billion to $ 183.92 Million, with a yearly change of -48.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $183.92 Million | -73.91% |
| 2025 | $704.81 Million | -42.47% |
| 2024 | $1.23 Billion | +12.69% |
| 2023 | $1.09 Billion | -23.12% |
| 2022 | $1.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 15th, 2026 the market cap of Embecta Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $183.92 Million USD |
| MoneyControl | $183.92 Million USD |
| MarketWatch | $183.92 Million USD |
| marketcap.company | $183.92 Million USD |
| Reuters | $183.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors… Read more